Treatment of Cellulitis Based on IDSA Guidelines

First-Line Antibiotic Selection

The Infectious Diseases Society of America recommends beta-lactam monotherapy as the standard of care for typical nonpurulent cellulitis, targeting beta-hemolytic streptococci and methicillin-sensitive Staphylococcus aureus, with cephalexin 500 mg orally every 6 hours for 5 days achieving 96% success rates 1, 2
Cephalexin 500 mg every 6 hours is the preferred first-line oral agent for typical cellulitis 1, 2
Other recommended oral agents include dicloxacillin 250-500 mg every 6 hours, amoxicillin, and penicillin V 250-500 mg four times daily 1, 2

The IDSA guidelines recommend treating for exactly 5 days if clinical improvement occurs, with extension only if the infection has not improved within this timeframe, representing high-quality evidence from randomized controlled trials 1, 2

MRSA is an uncommon cause of typical cellulitis and routine coverage is unnecessary, even in hospitals with high MRSA prevalence, but should be added when specific risk factors are present, such as penetrating trauma or injection drug use, purulent drainage or exudate, or evidence of MRSA infection elsewhere 1, 2
Clindamycin 300-450 mg orally every 6 hours is a recommended option for MRSA coverage, as it covers both streptococci and MRSA as monotherapy 1, 2

Hospitalization is recommended for patients with severe cellulitis, including those with systemic inflammatory response syndrome (SIRS) criteria, concern for deeper or necrotizing infection, severe immunocompromise or neutropenia, or poor adherence to outpatient therapy 1, 2
Vancomycin 15-20 mg/kg IV every 8-12 hours PLUS piperacillin-tazobactam 3.375-4.5 g IV every 6 hours is the recommended empiric regimen for severe infections with systemic toxicity 1, 2

Elevating the affected leg above heart level for at least 30 minutes three times daily can promote gravity drainage of edema and inflammatory substances 1, 2
Examining interdigital toe spaces carefully for tinea pedis, fissuring, scaling, or maceration, and treating these conditions, can eradicate colonization and reduce recurrent infection risk 1, 2

Systemic corticosteroids, such as prednisone 40 mg daily for 7 days, could be considered in non-diabetic adult patients to potentially hasten resolution, though evidence is limited (weak recommendation, moderate evidence) 1, 2

Annual recurrence rates are 8-20% in patients with previous leg cellulitis, and prophylactic antibiotics, such as oral penicillin V 250 mg twice daily for 4-52 weeks, may be considered for patients with 3-4 episodes per year despite treating predisposing factors 1, 2

Reassessing outpatients within 24-48 hours to ensure clinical improvement is recommended, and if no improvement is seen with appropriate first-line antibiotics, considering resistant organisms, cellulitis mimickers, or underlying complications is necessary 2